<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>51选刊 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-20T23:33:44+08:00</updated>
  <subtitle>如何选择SCI期刊，也是一门技巧。这里我们帮助大家选择拟投稿的SCI期刊！</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>大涨：这个热门领域的390本SCI期刊，最新即时IF出炉，226本已超2019年影响因子！</title>
    <updated>2021-01-19T00:28:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/cOc_0PUtYPkK1_DwULSV6Q</id>
    <link href="https://mp.weixin.qq.com/s/cOc_0PUtYPkK1_DwULSV6Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>干货！青年基金、面上项目的区别...</title>
    <updated>2021-01-19T00:28:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/NOPYfPRSOgyLVmpvDJfAIA</id>
    <link href="https://mp.weixin.qq.com/s/NOPYfPRSOgyLVmpvDJfAIA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Cell旗下新刊：两年内免版面费，最快3天完成审稿！</title>
    <updated>2021-01-19T00:28:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/aad5gTOJ_8ByUzvckhLiPQ</id>
    <link href="https://mp.weixin.qq.com/s/aad5gTOJ_8ByUzvckhLiPQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>300本国产SCI大盘点，或部分高分期刊，让你“高攀不起”！</title>
    <updated>2021-01-19T00:28:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/M1HbK-h8HYyyxTw14q1Z3A</id>
    <link href="https://mp.weixin.qq.com/s/M1HbK-h8HYyyxTw14q1Z3A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>这本SCI对国人超友好，一审不到3周，影响因子不断上升，今年3+</title>
    <updated>2021-01-19T00:28:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/w55uivmSMG5qd6XlIZ0OUw</id>
    <link href="https://mp.weixin.qq.com/s/w55uivmSMG5qd6XlIZ0OUw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>注意了，这本4分多的SCI强调：WB必须提供原始gel/blots图，且保证重复率</title>
    <updated>2021-01-19T00:28:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/E7IzKu27pSDWfdjefbEcBg</id>
    <link href="https://mp.weixin.qq.com/s/E7IzKu27pSDWfdjefbEcBg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>这本国产近5分的SCI，Letter和Research Highlight文章免发表费</title>
    <updated>2021-01-19T00:28:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/pacdjNxGQ57Ycq6YVC4GsQ</id>
    <link href="https://mp.weixin.qq.com/s/pacdjNxGQ57Ycq6YVC4GsQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Call for Papers (IF 4.362): 截稿2021年3月31日，平均三个月可接受</title>
    <updated>2021-01-19T00:28:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/i58ApWtvH6uDrGx_nbvGzA</id>
    <link href="https://mp.weixin.qq.com/s/i58ApWtvH6uDrGx_nbvGzA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>多年10+，这本Q1区的SCI，影响因子将继续增加！</title>
    <updated>2021-01-18T21:22:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/jHZ_O9KfK17rkQ8e3mjO4A</id>
    <link href="https://mp.weixin.qq.com/s/jHZ_O9KfK17rkQ8e3mjO4A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Theranostics：天津医大康春生团队设计出特异性靶向SARS-CoV-2棘突蛋白（S）的CRISPR基因编辑技术</title>
    <updated>2021-01-18T21:22:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/_vXDEWK36J3Jom8EGSs5ig</id>
    <link href="https://mp.weixin.qq.com/s/_vXDEWK36J3Jom8EGSs5ig" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Call for Papers (IF 4.362): 截稿2021年3月31日，平均三个月可接受</title>
    <updated>2021-01-18T21:22:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/AWiph2hpjsGgOCM-6agu-A</id>
    <link href="https://mp.weixin.qq.com/s/AWiph2hpjsGgOCM-6agu-A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>这本SCI去年8分，今年10分，发文量2000+ ，影响因子连续13年上涨，对国人超级友好</title>
    <updated>2021-01-18T21:22:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/ogQuM5NwS-J37uZ9RsjC_w</id>
    <link href="https://mp.weixin.qq.com/s/ogQuM5NwS-J37uZ9RsjC_w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>多年5分的SCI，明年要升为6分+，未来可期~</title>
    <updated>2021-01-18T21:22:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/G-W74FwCT6euA9PZ-MEpqQ</id>
    <link href="https://mp.weixin.qq.com/s/G-W74FwCT6euA9PZ-MEpqQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>年发文近1000篇的SCI，多年3分，今年将突破4分，3个月接受</title>
    <updated>2021-01-18T21:22:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/bZ8nAkV1ghxb2EXenpA9Cw</id>
    <link href="https://mp.weixin.qq.com/s/bZ8nAkV1ghxb2EXenpA9Cw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>一直不低于3分的Q1区SCI，今年将超4分，最快2个月接受</title>
    <updated>2021-01-18T21:22:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/FkVjzlnthO0A5N1CQWRdiw</id>
    <link href="https://mp.weixin.qq.com/s/FkVjzlnthO0A5N1CQWRdiw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>年发文近1500篇，2个月可接受，今年将冲破4分~</title>
    <updated>2021-01-18T21:22:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/RXCX5Kxd61xoueNpAVmVFw</id>
    <link href="https://mp.weixin.qq.com/s/RXCX5Kxd61xoueNpAVmVFw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国家自然基金：2020年第二批不端行为案件处理决定</title>
    <updated>2021-01-17T01:42:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/rAsiXUhm17sPSFfAMHk0Zg</id>
    <link href="https://mp.weixin.qq.com/s/rAsiXUhm17sPSFfAMHk0Zg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>这本Nature子刊，首个IF超10分，今年超11分，明年第三个IF将超13分</title>
    <updated>2021-01-17T01:42:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/1oAxveO_EiIZz78S-REVUw</id>
    <link href="https://mp.weixin.qq.com/s/1oAxveO_EiIZz78S-REVUw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>位居Q1区，去年8分，今年将超9分，这本SCI值得关注！</title>
    <updated>2021-01-17T01:42:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/uRIQ4gYFosJRHyL-43rVbQ</id>
    <link href="https://mp.weixin.qq.com/s/uRIQ4gYFosJRHyL-43rVbQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>这本8+的SCI，年发文1200多篇，一审21-28天</title>
    <updated>2021-01-17T01:42:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/Qh65Ah-cZoAs-Altd783WQ</id>
    <link href="https://mp.weixin.qq.com/s/Qh65Ah-cZoAs-Altd783WQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>